NDC 51429-010 - Neo-Oxy 100/100 MR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51429-010
- Package NDCs from labels
- 51429-010-03
- Manufacturer
- Pharmgate Animal Health | Pharmgate Inc.
- Effective date
- 2026-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neo-Oxy 100/100 MR ® | Pharmgate Animal Health | Pharmgate Inc. | 2026-01-07 | VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51429-010-03 | Neo-Oxy 100/100 MR | 22.68 kg in 1 DRUM | POWDER | 22.68 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Neomycin Sulfate | ACTIVE INGREDIENT | 057Y626693 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Hydrochloride | ACTIVE INGREDIENT | 4U7K4N52ZM | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Anhydrous | ACTIVE MOIETY | SLF0D9077S | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Triple antibiotic and pain relief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Cardinal Health 110 dba LEADER | f4c521d9-dd05-1c23-e053-2995a90a6e2c | 2025-05-13 | Warnings | 057Y626693 |
| Tripleantibioticointmentandpainrelief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Trifecta Pharmaceuticals USA | 34f1db74-6506-d53d-e063-6394a90ac400 | 2025-05-12 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Bausch & Lomb Incorporated | b0ee85dd-5fe1-46a3-9bff-606e489d20b1 | 2025-04-30 | Warnings, Adverse reactions | 057Y626693 |
| Triple Antibiotic plus Lidocaine | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE, LIDOCAINE | TRIFECTA PHARMACEUTICALS USA LLC | 14fda967-54ba-c964-e063-6294a90a21ee | 2025-04-24 | Warnings | 057Y626693 |
| NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE SUSPENSION/ DROPS | DirectRx | d5e00bad-abb4-63ad-e053-2a95a90a5abb | 2025-04-15 | Warnings, Adverse reactions | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | Front Pharmaceutical PLC | 3244d91e-6c6b-a351-e063-6294a90aa02d | 2025-04-08 | Warnings | 057Y626693 |
| Redicare Triple Antibiotic First Aid | TRIPLE ANTIBIOTIC FIRST AID OINTMENT | Redicare LLC | 9468979d-446e-e4be-e053-2995a90a3f21 | 2025-03-05 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 057Y626693 |
| The Life Safety Pro Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 64a7331f-98a6-4052-85b9-695c83b3bd16 | 2025-02-19 | Warnings | 057Y626693 |
| Sheffield Triple Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE | Sheffield Pharmaceuticals LLC | 1aa95046-c1f7-4fc7-acac-839065d998f6 | 2025-02-17 | Warnings | 057Y626693 |
| Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Welly Health PBC | 9446375d-4bb4-4bb1-bdc2-c18e995bfe26 | 2025-01-29 | Warnings | 057Y626693 |
| Equate Antibiotic Plus Pain, Itch, Scar Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | WalMart | 2b743271-4f58-4ba1-a04c-560f7f8a547e | 2025-01-16 | Warnings | 057Y626693 |
| Equate Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | WalMart | e08b427f-d070-4521-ad3c-faf295531791 | 2025-01-16 | Warnings | 057Y626693 |
| Antibiotic Application | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | CMC Group, Inc. | da436c35-a98f-4df7-9d23-885564734cef | 2025-01-13 | Warnings | 057Y626693 |
| Drs. pharmacy triple antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE OINTMENT | OL PHARMA TECH, LLC | bb730976-0045-c0ae-e053-2a95a90af34e | 2025-01-09 | Warnings | 057Y626693 |
| Drs. Pharmacy Triple Antibiotic Plus | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE | OL PHARMA TECH, LLC Drs PHARMACY | d037bfb8-0d8c-4eda-e053-2995a90ae1f2 | 2025-01-09 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND BACITRACIN ZINC | Bausch & Lomb Incorporated | f3231f1c-665e-4efa-baa1-83bf296b2f8f | 2025-01-02 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone | NEOMYCIN SULFATE AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND HYDROCORTISONE | Bausch & Lomb Incorporated | 3b00eb5c-dd98-467e-a883-04c37a8ecc42 | 2025-01-02 | Warnings, Adverse reactions | 057Y626693 |
| AVON HeXashield Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCL | Tai Guk Pharm. Co., Ltd. | 8e0cb861-d8aa-1f71-e053-2a95a90aaa88 | 2025-01-01 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Trifecta Pharmaceuticals USA LLC | 087694c2-4b1b-e293-e063-6294a90a961f | 2024-12-31 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.